A comparative study of Dhanyakadi Churna and Panchnimbadi Churna in 62 patients of Urdhwag Amlapitta or Gastro Oesophageal Reflux Disease.

An Open, Randomized, Comparative Clinical Study of Dhanyakadi Churna and Panchnimbadi Churna in the Management of Urdhwag Amlapitta - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086950

Enrollment

Registered

2025-05-14

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Age 18 to 60 years Gender All genders Symptoms Urdhwag Amlapitta Hrit Kantha Dah, Tikt Amlodgar, Utklesha, Avipak, Aruchi, Klama. Compliance Patients who are willing and able to adhere to the study protocol, including prescribed treatments and follow-up schedules. Health Status Patients with no significant comorbidities that could interfere with the Study outcomes or the safety of the participant, as determined by a clinical assessment. Medication History Patients who have not used any other Ayurvedic or allopathic treatments for Urdhwag Amlapitta in the past two weeks.

Exclusion criteria

Exclusion criteria: Pregnancy and Lactation Psychiatric Disorders Chronic or Severe Medical Conditions Recent Surgery Current Use of Confounding Medications Substance Abuse Participation in Other Trial

Design outcomes

Primary

Measure	Time frame
Hrit Kantha daha Tikta amlodgar Utklesha Avipak Aruchi Klama Timepoint: 3 weeks	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr. Anaya Ashish Pathrikar

APMS Ayurved Mahavidyalaya Sion

tartenisha27@gmail.com9082901128

Outcome results